Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Sell
871
-283
-25% -$80.6K ﹤0.01% 602
2026
Q1
$200K Sell
1,154
-12
-1% -$2.46K ﹤0.01% 764
2025
Q4
$299K Sell
1,166
-52
-4% -$13.6K ﹤0.01% 652
2025
Q3
$317K Sell
1,218
-149
-11% -$39.2K ﹤0.01% 639
2025
Q2
$334K Buy
1,367
+48
+4% +$12K ﹤0.01% 596
2025
Q1
$349K Buy
1,319
+5
+0.4% +$1.35K ﹤0.01% 521
2024
Q4
$333K Sell
1,314
-154
-10% -$41.3K ﹤0.01% 500
2024
Q3
$549K Sell
1,468
-240
-14% -$85.4K 0.01% 429
2024
Q2
$592K Buy
1,708
+582
+52% +$197K 0.01% 331
2024
Q1
$390K Sell
1,126
-293
-21% -$111K 0.01% 324
2023
Q4
$690K Buy
1,419
+1,230
+651% +$606K 0.01% 204
2023
Q3
$84K Buy
189
+40
+27% +$18.8K ﹤0.01% 672
2023
Q2
$72K Sell
149
-413
-73% -$208K ﹤0.01% 581
2023
Q1
$287K Buy
562
+200
+55% +$98.9K ﹤0.01% 420
2022
Q4
$175K Buy
362
+200
+123% +$105K ﹤0.01% 500
2022
Q3
$75K Buy
162
+50
+45% +$24.3K ﹤0.01% 624
2022
Q2
$49K Buy
+112
New +$49.8K ﹤0.01% 686

Other funds holding HUM

Blue Trust Inc's HUM Position: Q2 2026 in Review

Blue Trust Inc reduced its Humana (HUM) stake by 25% in Q2 2026, selling an estimated $80.6K and leaving 871 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

Blue Trust Inc first reported a position in HUM in Q2 2022 and has held it in 17 quarters since. The position peaked at $690K in Q4 2023. 188 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Blue Trust Inc held 871 shares of Humana worth $346K as of Q2 2026.
  • Blue Trust Inc sold 283 Humana shares in Q2 2026, an estimated $80.6K.
  • Humana made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #602 holding.
  • Blue Trust Inc first reported a position in Humana in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Humana position peaked at $690K in Q4 2023.
  • 188 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.